Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Race Oncology Ltd. ( (AU:RAC) ) just unveiled an announcement.
Race Oncology Ltd has announced the quotation of 31,449 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of September 18, 2025. This move is part of the company’s ongoing efforts to enhance its financial flexibility and support its strategic initiatives in the oncology sector, potentially impacting its market positioning and providing value to its stakeholders.
More about Race Oncology Ltd.
Race Oncology Ltd is a company operating in the biotechnology industry, primarily focused on developing cancer therapies. The company is engaged in the research and development of innovative treatments aimed at addressing unmet medical needs in oncology.
Average Trading Volume: 132,926
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$312.8M
For detailed information about RAC stock, go to TipRanks’ Stock Analysis page.